Search
Search Results
##search.searchResults.foundPlural##
-
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
3009PDF: 2530HTML: 175 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3213PDF: 1202HTML: 141 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
3670PDF: 1380HTML: 460 -
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
2304PDF: 796HTML: 2081 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3249PDF: 2244HTML: 1257 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
1801PDF: 1419HTML: 328 -
-
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
3847PDF: 1065HTML: 1892Fig.1: 186Fig. 2: 88Table 1: 158Table2: 173Table 3: 158 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3188PDF: 1345HTML: 56 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4465PDF: 1437HTML: 2191Untitled: 153Untitled: 170Untitled: 180Untitled: 155Untitled: 148 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1208PDF: 755HTML: 3088 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
2906PDF: 1313HTML: 5780Fig1-Ag-Pil: 153Ag-Pil Fig.2: 153 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1111PDF: 427HTML: 18517Figure 1: 122Figure 2: 112Figure 3: 136Figure 4: 162Figure 5: 136 -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1059HTML: 263PDF: 844Suppl. Files: 410 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1034PDF: 392HTML: 111 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2338PDF: 1505HTML: 2314Table1: 156 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
1866PDF: 728HTML: 1009 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3012PDF: 921HTML: 1971 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1342PDF: 652HTML: 299 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
2855PDF: 778HTML: 7094Kost Fig1: 135Kost Fig 2: 126Kost Fig3: 124Kost Fig 4: 130Kost Fig5: 131Kost fig 6: 115 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2073PDF: 1252HTML: 16957Bassan Fig.1: 118Bassan Fig.2: 117Bassan Fig.4: 101Fig.3: 142 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1278PDF: 816HTML: 171 -
NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION
1560PDF: 907HTML: 1745Tables: 143 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
964PDF: 412HTML: 186 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1144PDF: 571HTML: 3043 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
3689PDF: 1794HTML: 5114Table 1: 156 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
2978PDF: 713HTML: 2879Figure 1a and 1b: 119Figure 2: 117Figure 3: 138Figure 4: 119Figure 5: 122Tables 1-5: 117 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
3984PDF: 1393HTML: 1505Untitled: 185 -
Skin Manifestations associated with Mantle cell Lymphoma: a case report
1318PDF: 682HTML: 2067Untitled: 139Untitled: 133Untitled: 147Untitled: 138Untitled: 149 -
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
4114PDF: 1498HTML: 2974Tables and Images: 163 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1371PDF: 514HTML: 157 -
The labyrinth of pyrexia of unknown origin: A case of intravascular B cell lymphoma
1612PDF: 601HTML: 2355Untitled: 118Figure 1 a: 125Figure 1 b: 125Fig 1 c: 112Figure 1 d: 153 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
1232PDF: 313HTML: 167 -







